← FDA DRUG APPROVALS

FDA ANDA · ANDA086276

TRIAMCINOLONE ACETONIDE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA086276
TYPE
ANDA
ORIGINAL APPROVAL
1979-04-10
LATEST ACTION
1993-04-08
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

TRIAMCINOLONE ACETONIDEDiscontinued
TRIAMCINOLONE ACETONIDE 0.1% · CREAM · TOPICAL

Approval history

1993-04-08Labeling · Supplement 48AP
1992-11-16Labeling · Supplement 47AP
1991-03-05Labeling · Supplement 45AP
1990-12-07Labeling · Supplement 44AP
1990-01-03Manufacturing (CMC) · Supplement 40AP
1989-11-09Labeling · Supplement 41AP
1989-05-11Manufacturing (CMC) · Supplement 37AP
1989-05-01Labeling · Supplement 39AP
1989-02-16Labeling · Supplement 38AP
1988-10-27Manufacturing (CMC) · Supplement 35AP
1987-06-22Manufacturing (CMC) · Supplement 27AP
1986-10-07Manufacturing (CMC) · Supplement 25AP
1985-12-03Manufacturing (CMC) · Supplement 22AP
1985-12-03Manufacturing (CMC) · Supplement 21AP
1985-01-14Manufacturing (CMC) · Supplement 16AP
1985-01-14Manufacturing (CMC) · Supplement 15AP
1984-11-20Manufacturing (CMC) · Supplement 17AP
1984-06-12Manufacturing (CMC) · Supplement 13AP
1983-07-07Manufacturing (CMC) · Supplement 12AP
1983-06-09Manufacturing (CMC) · Supplement 11AP
1982-06-03Manufacturing (CMC) · Supplement 10AP
1982-04-28Manufacturing (CMC) · Supplement 9AP
1979-04-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →